Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Research and Markets: Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Pipeline Review, H1 2015 - 24 Companies & 15 Drug Profiles

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/09/2015 | 09:48am EDT

Research and Markets (http://www.researchandmarkets.com/research/g4d563/ankylosing) has announced the addition of the "Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Amgen Inc.
  • Avesthagen Limited
  • BIOCAD
  • Biocon Limited
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Celltrion, Inc.
  • Covagen AG
  • Epirus Biopharmaceuticals, Inc.
  • Genor BioPharma Co., Ltd.
  • Inbiopro Solutions Pvt. Ltd.
  • Innovent Biologics, Inc.
  • Johnson & Johnson
  • Lupin Limited
  • Mabion SA
  • Momenta Pharmaceuticals, Inc.
  • Novartis AG
  • Oncobiologics, Inc.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Protalix BioTherapeutics, Inc.
  • Sandoz International GmbH
  • Shanghai Pharmaceutical Co., Ltd.
  • Therapeutic Proteins International, LLC

Drug Profiles

  • adalimumab biosimilar
  • apremilast
  • BI-655066
  • COVA-322
  • etanercept biosimilar
  • golimumab
  • golimumab biosimilar
  • IBI-303
  • IBPM-004AM
  • IBPM-005IX
  • infliximab biosimilar
  • INV-17
  • secukinumab
  • thalidomide
  • tofacitinib

For more information visit http://www.researchandmarkets.com/research/g4d563/ankylosing


© Business Wire 2015
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
04:38aAVISTA : Washington utility Avista commits to 100% clean energy by 2045
AQ
04:37aBLACKROCK : No signs of global recession in next 12 months - BlackRock's Fink
RE
04:37aNEWMONT MINING : and Goldcorp Successfully Create Worlds Leading Gold Company
AQ
04:37aBEMETALS : Upsizes Previously Announced Non-Brokered Financing to $6.25 Million
AQ
04:36aHECLA MINING : Reports 2.9 Million Ounces of Silver and 60,021 Ounces of Gold Production in First Quarter 2019
AQ
04:36aSUPERIOR GOLD INC : . Announces First Quarter 2019 Production Results
AQ
04:35aGULFPORT ENERGY : Reports Production Drops 2%
AQ
04:35aTELEFONAKTIEBOLAGET LM ERICSSON : Swedish Ericsson and Swisscom launch Europe's first large scale 5G network
AQ
04:35aIBERDROLA : New Yorks VDER gets a few tweaks
AQ
04:35aENGIE : turns sod on 160MW Jumbo Hill
AQ
Latest news "Companies"
Advertisement